Emovi, Inc. to Demonstrate New Technology for Advanced Knee Care at the 2021 Annual American Academy of Orthopaedic Surgeons Conference (AAOS)
Montreal, Quebec (August 29, 2021) – Emovi, Inc., manufacturer of the KneeKGTM device, today announced that it will exhibit at the American Academy of Orthopaedic Surgeons (AAOS) annual meeting and conference in San Diego, California, from Aug. 31 – Sept. 3.
The KneeKG is the first clinically validated tool developed for surgeons and clinicians, providing objective and quantifiable data to understand the causes of orthopedic knee pain and to restore knee function. Clinical applications include patients who have impaired movement functions of an orthopaedic cause such as: knee osteoarthritis, anterior knee pain (including patellofemoral pain syndrome), iliotibial band friction syndrome, patellar tendinopathy, tendinitis, ligament and meniscus injuries.
“We are excited about deepening our relationships with orthopaedic surgeons and industry experts during AAOS,” said Michelle Laflamme, CEO Emovi. “The knee is one of the most frequently injured joints that can end up requiring surgical intervention. Orthopaedic surgeons report the need for dynamic, 3D data on the knee joint while weight-bearing to support surgical planning, direct pre-and post-op care, and objectively discharge patients supported with distinct data. The KneeKG ultimately allows clinicians to provide better, more robust patient care and improve providers’ experiences.”
Just as vital organs, such as the heart or kidneys, are examined to determine disease and dysfunctions, the KneeKG assesses and documents the knee function and highlights any biomechanical dysfunction with extraordinary accuracy and reliability. The clinical data extracted from the computerized assessment defines the exact mechanical issue within the knee, giving healthcare professionals the medically necessary information to enhance treatment decision-making and address the impaired biomechanical markers. With the specified data from the KneeKGTM system, healthcare professionals can help their patients achieve pain reduction, improved treatment(s), and better outcomes, which will improve patient satisfaction and quality of life.
Visitors of AAOS will be able to see a full demonstration of the KneeKG and meet the Emovi team at booth #4906 throughout the conference.
###
About Emovi Inc.
Emovi stands for Emotion • Movement • Vision. These attributes are at the core of who we are as a healthcare innovation company. Our mission is to bring solutions to patients for the treatment of knee injuries and knee osteoarthritis. We are motivated every day by a clear goal: to empower patients to regain their active lifestyle as quickly as possible and enable them to improve their quality of life. Through our AI-powered solutions, we strive to deliver consistent results, positive patient outcomes and efficiency in patient workflow.
The company is headquartered in Laval, Quebec, Canada. In partnership with the Quebec university research community, including the CRCHUM, Ecole de Technologie superieure(ETS), and TELUQ, Emovi completed the development of the KneeKG, an FDA 510K cleared, HealthCanada licensed and CE Marked medical device appropriate for assessing the 3D motion of the knee for patients who have impaired movement functions of an orthopedic cause. The technique is described as a Knee Kinesiography exam. www.emovi.ca
